Cytopathology

HOW WELL DO CANCER DRUGS HIT THEIR TARGETS?

Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets in the body.

“CANCEROUS CELLS WORK TOGETHER TO INFILTRATE THE BRAIN”

Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumour work together to infiltrate the brain.

MAGNETS ISOLATE CIRCULATING TUMOUR CELLS

Scientists claim that magnets could be used in the body to detect tumour cells that other diagnostic techniques might miss.

HPV primary screening

Following a review of its delivery strategy, NHS England has agreed to begin a one-stage procurement process to reconfigure provider laboratories to support the roll-out of Human Papilloma Virus (HPV) primary screening into the NHS Cervical Cancer Screening Programme in England.

Poliovirus therapy for recurrent glioblastoma

A genetically modified poliovirus therapy shows significantly improved long-term survival for patients with recurrent glioblastoma.

Viral suppression helps to prevent AIDS-defining cancers

Early, sustained antiretroviral therapy that results in long-term viral suppression, helps to prevent AIDS-defining cancers and, to a lesser degree, non-AIDS-defining cancers, it is claimed.

News flow cytometer

Merck, a leading science and technology company, has now launched its new CellStream flow cytometry system.

April Journal-based learning

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

Primary HPV cervical screening

Following meetings with the British Association for Cytopathology (BAC), Public Health England (PHE) and the IBMS, the following has been agreed.

British Journal of Biomedical Science Issue 2 2018: a synopsis

Issue 2 of our journal is now completed. By the time you read this, the hardcopy may already have landed on your doormats, and those of you who have been to the website will already have accessed and read some of the papers. Editor Andrew Blann outlines the content in the latest issue.

Managing uncertainty in andrology

With andrology gaining more prominence as a discipline, David Sanders talks through the pre-examination process.

Top